.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 202346

« Back to Dashboard
NDA 202346 describes LIDOCAINE, which is a drug marketed by Belmora Llc, Septodont Inc, Teligent Pharma Inc, Taro, Mylan Technologies, Actavis Labs Ut Inc, Amneal Pharms, Fougera, Glenmark Pharms Ltd, Tolmar, Fougera Pharms, Hi Tech Pharma, Intl Medication, Roxane, Graham Chem, Eurohlth Intl Sarl, Abraxis Pharm, Bel Mar, Vintage, Hospira, Miles, G And W Labs Inc, Elkins Sinn, Watson Labs, Akorn, Gd Searle Llc, Watson Labs Inc, Mylan Labs Ltd, Luitpold, Abbott, Luitpold Pharms Inc, Wockhardt, Wyeth Ayerst, Dell Labs, Paco, Lyphomed, Baxter Hlthcare, B Braun, Eastman Kodak, Empi, Fresenius Kabi Usa, Aurobindo Pharma Ltd, and Actavis Mid Atlantic, and is included in one hundred and six NDAs. It is available from twenty-eight suppliers. Additional details are available on the LIDOCAINE profile page.

The generic ingredient in LIDOCAINE is epinephrine; lidocaine hydrochloride. There are seventeen drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the epinephrine; lidocaine hydrochloride profile page.

Summary for NDA: 202346

Tradename:
LIDOCAINE
Applicant:
Mylan Technologies
Ingredient:
lidocaine
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 202346

Ingredient-typeAmides
Physiological EffectLocal Anesthesia

Suppliers and Packaging for NDA: 202346

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LIDOCAINE
lidocaine
PATCH;TOPICAL 202346 ANDA Mylan Pharmaceuticals Inc. 0378-9055 0378-9055-93 30 POUCH in 1 CARTON (0378-9055-93) > 1 PATCH in 1 POUCH (0378-9055-16)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:PATCH;TOPICALStrength5%
Approval Date:Aug 7, 2015TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc